Search Results 1661-1670 of 16845 for dermatitis atópica

  1. A Study of Severe Combined Immunodeficiency Disorders - Mayo Clinic

    Generalized skin rash; Maternal lymphocytes not detected; Absent or low (< 30% lower limit of normal) T cell proliferation to antigens; > 80% of CD4 T cells ...

  2. Mayo Clinic Q and A: Combating allergies, asthma during COVID-19

    Avoid spraying your septum or nasal bone, which can thin the skin and cause bleeding. Rather, tilt the head down, shake the bottle and then aim toward the ...

  3. Osteomyelitis - Doctors and departments - Mayo Clinic

    Onyango, M.D.. Internist; Pediatrician. Phoenix, AZ. Areas of focus: Lumbar puncture, Central venous catheterization, Skin biopsy, Pelvic exam, Hospitalization, ...

  4. Osteomyelitis - Doctors and departments - Mayo Clinic

    ... Skin infection, Joint infection, Infection in the immunocompromised, Gastrointestinal infection, Infection, Prosthetic joint infection, Bacteremia ...

  5. Combination Chemotherapy and Trastuzumab in Treating Women With Metastatic Breast Cancer - Mayo Clinic

    No other invasive malignancy within the past 5 years except curatively treated basal cell or squamous cell skin cancer or carcinoma in situ of the cervix; No ...

  6. PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Subjects With Stage IV Untreated Pancreatic Cancer - Mayo Clinic

    History of another primary cancer within the last 3 years with the exception of non-melanoma skin cancer or curatively-treated cervical cancer in-situ.

  7. Study of Cabozantinib (XL184) vs Placebo in Subjects With Hepatocellular Carcinoma Who Have Received Prior Sorafenib - Mayo Clinic

    Diagnosis of another malignancy within 2 years before randomization, except for superficial skin cancers, or localized, low-grade tumors. Participating Mayo ...

  8. Carfilzomib and Dexamethasone in Treating Patients With Multiple Myeloma Who Previously Underwent a Stem Cell Transplant - Mayo Clinic

    Other active malignancy requiring therapy; EXCEPTIONS: non-melanotic skin cancer or carcinoma-in-situ of the cervix; NOTE: if there is a history or prior ...

  9. A Study to Evaluate the Safety and Effectiveness of AB928-Based Treatment Combinations to Treat Patients with Metastatic Colorectal Cancer - Mayo Clinic

    except for malignancies such as non-melanoma skin carcinoma or ductal carcinoma in situ - Active tuberculosis - Treatment with therapeutic oral or ...

  10. Phase 1 Study of PLX7486 as Single Agent in Patients With Advanced Solid Tumors - Mayo Clinic

    ... skin, melanoma in situ, or carcinoma in-situ of the cervix; Chemotherapy within 28 days prior to C1D1; Biological therapy within 5 half-lives prior to C1D1 ...